Davis R M Inc. maintained its position in Xylem Inc. (NYSE:XYL) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,520 shares of the industrial products company’s stock at the end of the second quarter. Davis R M Inc.’s holdings in Xylem were worth $472,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of XYL. Asset Planning Services Ltd. increased its position in Xylem by 0.3% in the first quarter. Asset Planning Services Ltd. now owns 2,107 shares of the industrial products company’s stock worth $106,000 after buying an additional 7 shares in the last quarter. Contravisory Investment Management Inc. increased its stake in shares of Xylem by 96.1% in the first quarter. Contravisory Investment Management Inc. now owns 2,345 shares of the industrial products company’s stock worth $118,000 after buying an additional 1,149 shares in the last quarter. Cribstone Capital Management LLC increased its stake in shares of Xylem by 1,214.6% in the first quarter. Cribstone Capital Management LLC now owns 2,432 shares of the industrial products company’s stock worth $124,000 after buying an additional 2,247 shares in the last quarter. CENTRAL TRUST Co increased its stake in shares of Xylem by 160.3% in the second quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock worth $146,000 after buying an additional 1,635 shares in the last quarter. Finally, FNY Partners Fund LP bought a new stake in shares of Xylem during the first quarter worth about $151,000. Hedge funds and other institutional investors own 87.16% of the company’s stock.
Xylem Inc. (NYSE XYL) traded up 0.14% during trading on Friday, reaching $59.03. The company’s stock had a trading volume of 630,930 shares. The stock has a 50 day moving average price of $57.50 and a 200 day moving average price of $52.31. Xylem Inc. has a 1-year low of $45.60 and a 1-year high of $60.71. The stock has a market capitalization of $10.60 billion, a PE ratio of 38.11 and a beta of 1.18.
Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, August 1st. The industrial products company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.02. Xylem had a return on equity of 17.26% and a net margin of 6.58%. The company had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the prior year, the business earned $0.48 EPS. Xylem’s revenue was up 24.9% on a year-over-year basis. Analysts anticipate that Xylem Inc. will post $2.37 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 20th. Shareholders of record on Thursday, August 31st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, August 29th. This represents a $0.72 annualized dividend and a yield of 1.22%. Xylem’s dividend payout ratio (DPR) is 46.45%.
COPYRIGHT VIOLATION NOTICE: “Davis R M Inc. Continues to Hold Position in Xylem Inc. (XYL)” was first posted by BNB Daily and is the property of of BNB Daily. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.baseball-news-blog.com/2017/08/19/davis-r-m-inc-has-472000-stake-in-xylem-inc-xyl-updated.html.
A number of brokerages recently issued reports on XYL. Cowen and Company restated an “outperform” rating and issued a $70.00 price target (up from $60.00) on shares of Xylem in a research report on Wednesday, August 9th. Oppenheimer Holdings, Inc. raised their price target on Xylem from $60.00 to $66.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. Barclays PLC upgraded Xylem from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $51.00 to $59.00 in a research report on Monday, May 15th. BMO Capital Markets started coverage on Xylem in a research report on Wednesday, June 21st. They set an “outperform” rating and a $60.00 target price for the company. Finally, BidaskClub upgraded Xylem from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Five analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $59.00.
In other Xylem news, Director Steven R. Loranger sold 66,132 shares of the company’s stock in a transaction dated Thursday, June 29th. The stock was sold at an average price of $55.01, for a total transaction of $3,637,921.32. Following the sale, the director now owns 65,030 shares in the company, valued at approximately $3,577,300.30. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Kenneth Napolitano sold 9,052 shares of the stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $60.16, for a total value of $544,568.32. Following the completion of the transaction, the insider now owns 35,303 shares in the company, valued at approximately $2,123,828.48. The disclosure for this sale can be found here. 0.75% of the stock is owned by corporate insiders.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.